Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Fingleton

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Cytotechnology|January 1, 1993
Role of matrix metalloproteinases in invasion and metastasis: biology, diagnosis and inhibitorsS McDonnell, B Fingleton
Biochemical Society Transactions|May 1, 1997
Cytokine regulation of matrilysin gene expressionB Fingleton, S McDonnell
Current Opinion in Oncology|September 14, 2001
Matrix metalloproteinases as targets for therapy in Kaposi sarcomaB Fingleton, L M Matrisian
Neoplasia (New York, N.Y.)|January 5, 2002
Matrilysin [MMP-7] expression selects for cells with reduced sensitivity to apoptosisB Fingleton, T Vargo-Gogola, H C Crawford, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2000
Matrix metalloproteinases: biologic activity and clinical implicationsA R Nelson, B Fingleton, M L Rothenberg, et al.
Current Biology : CB|December 23, 1999
The metalloproteinase matrilysin proteolytically generates active soluble Fas ligand and potentiates epithelial cell apoptosisW C Powell, B Fingleton, C L Wilson, et al.
The Journal of Clinical Investigation|January 22, 2000
Matrix metalloproteinase-7-dependent release of tumor necrosis factor-alpha in a model of herniated disc resorptionH Haro, H C Crawford, B Fingleton, et al.
The Journal of Clinical Investigation|January 22, 2000
Matrix metalloproteinase-3-dependent generation of a macrophage chemoattractant in a model of herniated disc resorptionH Haro, H C Crawford, B Fingleton, et al.
Molecular and Cellular Biology|February 7, 2001
The PEA3 subfamily of Ets transcription factors synergizes with beta-catenin-LEF-1 to activate matrilysin transcription in intestinal tumorsH C Crawford, B Fingleton, M D Gustavson, et al.
Journal of Cell Science|December 12, 2000
Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1V Noë, B Fingleton, K Jacobs, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Cytotechnology|January 1, 1993
Role of matrix metalloproteinases in invasion and metastasis: biology, diagnosis and inhibitorsS McDonnell, B Fingleton
Biochemical Society Transactions|May 1, 1997
Cytokine regulation of matrilysin gene expressionB Fingleton, S McDonnell
Current Opinion in Oncology|September 14, 2001
Matrix metalloproteinases as targets for therapy in Kaposi sarcomaB Fingleton, L M Matrisian
Neoplasia (New York, N.Y.)|January 5, 2002
Matrilysin [MMP-7] expression selects for cells with reduced sensitivity to apoptosisB Fingleton, T Vargo-Gogola, H C Crawford, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2000
Matrix metalloproteinases: biologic activity and clinical implicationsA R Nelson, B Fingleton, M L Rothenberg, et al.
Current Biology : CB|December 23, 1999
The metalloproteinase matrilysin proteolytically generates active soluble Fas ligand and potentiates epithelial cell apoptosisW C Powell, B Fingleton, C L Wilson, et al.
The Journal of Clinical Investigation|January 22, 2000
Matrix metalloproteinase-7-dependent release of tumor necrosis factor-alpha in a model of herniated disc resorptionH Haro, H C Crawford, B Fingleton, et al.
The Journal of Clinical Investigation|January 22, 2000
Matrix metalloproteinase-3-dependent generation of a macrophage chemoattractant in a model of herniated disc resorptionH Haro, H C Crawford, B Fingleton, et al.
Molecular and Cellular Biology|February 7, 2001
The PEA3 subfamily of Ets transcription factors synergizes with beta-catenin-LEF-1 to activate matrilysin transcription in intestinal tumorsH C Crawford, B Fingleton, M D Gustavson, et al.
Journal of Cell Science|December 12, 2000
Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1V Noë, B Fingleton, K Jacobs, et al.
Pageof 2